Document Detail

Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis.
MedLine Citation:
PMID:  21269575     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: Rheumatoid arthritis is associated with an increased risk of adverse pregnancy outcomes. TNF inhibitors are effective in the treatment of signs and symptoms of the disease although their safety during pregnancy is debated.
METHODS: Two cases of women with rheumatoid arthritis in complete remission of the disease with etanercept who decided to continue the therapy throughout their pregnancy are presented. A longitudinal evaluation of the disease activity showed a satisfactory control and good pregnancy outcomes were obtained. A flare of the disease after delivery was not observed.
CONCLUSIONS: Etanercept seems to be safe during pregnancy and lactation. A good control of the activity of the disease was reported throughout the pregnancy and during puerperium, when a reactivation of rheumatoid arthritis is often observed.
Crescenzio Scioscia; Marco Scioscia; Maria Grazia Anelli; Emanuela Praino; Stefano Bettocchi; Giovanni Lapadula
Related Documents :
17702365 - Outcome of pregnancy in women after pulmonary autograft valve replacement for congenita...
15507945 - Previous pregnancy loss: risks related to severity of preterm delivery.
8035295 - Multiple fetuses, growth deviations and mortality in a very preterm birth cohort.
16842635 - Proteomics, part ii: the emerging role of proteomics over genomics in spontaneous prete...
25262455 - Correlation of continuous glucose monitoring profiles with pregnancy outcomes in nondia...
7814715 - Pregnancy attrition associated with pregnancy testing by rectal palpation.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2011-02-23
Journal Detail:
Title:  Clinical and experimental rheumatology     Volume:  29     ISSN:  0392-856X     ISO Abbreviation:  Clin. Exp. Rheumatol.     Publication Date:    2011 Jan-Feb
Date Detail:
Created Date:  2011-02-24     Completed Date:  2011-05-03     Revised Date:  2012-08-27    
Medline Journal Info:
Nlm Unique ID:  8308521     Medline TA:  Clin Exp Rheumatol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  93-5     Citation Subset:  IM    
Department of Internal Medicine and Public Health, University of Bari, Bari, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy*,  physiopathology
Health Status
Immunoglobulin G / therapeutic use*
Infant, Newborn
Lactation / drug effects
Live Birth*
Pregnancy Complications / drug therapy*
Receptors, Tumor Necrosis Factor / therapeutic use*
Remission Induction
Severity of Illness Index
Young Adult
Reg. No./Substance:
0/Antirheumatic Agents; 0/Immunoglobulin G; 0/Receptors, Tumor Necrosis Factor; 185243-69-0/TNFR-Fc fusion protein
Comment In:
Clin Exp Rheumatol. 2012 May-Jun;30(3):453   [PMID:  22704593 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Vitamin D3 ameliorates herpes simplex virus-induced Behcet's disease-like inflammation in a mouse mo...
Next Document:  Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloart...